로고
Oct. 18(Wed) - 20(Fri), 2023 BEXCO, BUSAN, KOREA 로고

  • Home
  • Login
  • Sign Up
  • Contact us
“ Advances in Cancer Genetics:
Past, present, and future ”
International Conference of the Genetics Society of Korea
Oct. 18(Wed) - 20(Fri), 2023 BEXCO, Busan, Korea
Programs
  • Programs
  • Forums

Forums

Drug R&D

October 19 (Thu) 10:00-12:00
ROOM 323
Chair: Sunghoi Hong (Korea University)
10:00-10:30
Gene therapeutics via ribozyme-based RNA editing technology
Seong-Wook Lee
Dankook University / Rznomics Inc., Korea
10:30-11:00
Targeting synapse as a common pathology in neurological diseases from the perspective of FAM19A5 and its monoclonal antibody.
Joseph Park
Clinical Development, Neuracle Science Co., Ltd., Korea
11:00-11:30
From Lab to Clinic: A Comprehensive Guide to Developing iPS Cell-Derived Therapies
Yoojun Nam
YiPSCELL, Korea
11:30-12:00
The Present and Future of Korea's Bio Industry
Soo-Jin Choi
Tech University of Korea, Korea

K-MEDI hub

October 19 (Thu) 10:00-12:00
ROOM 321-322
Chair: KilSoo Kim (Preclinical Research Center, K-MEDI hub PRC)
           Un-Kyung Kim (Kyungpook National University)
10:00-10:30
Discovery of DN203368, a dual inverse agonist regulating estrogen-related receptor beta and gamma (ERRβ/γ), as a novel orally active anticancer agent against colorectal cancer
Yong Hyun Jeon
Preclinical Research Center, K-MEDI hub PRC, Korea
10:30-11:00
Targeting Hippo-YAP-TEAD Signaling Pathway for Therapeutic Intervention
Boksik Cha
New Drug Development Center, K-MEDI hub, Korea
11:00-11:30
ETN101 inhibits tumor growth of hepatocellular carcinoma through multitargeted inhibition of receptor tyrosine kinases
Garam Choi
Etnova Therapeutics Corp., Korea
11:30-12:00
Non-clinical development of AAV9 gene therapy products delivering Nurr1 and Foxa2 genes for therapeutic approach to Alzheimer's Disease
Seonghoon Lee
Innopeutics Corporation, Korea